The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation
PLOS Biology · 2025
DOI: 10.1371/journal.pbio.3003486 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Xiaohui Deng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen Uni…. Hauptthemen laut MEDLINE: HIV-1, RNA-Binding Proteins, RNA Stability, Virus Activation. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases.
Abstract (Originalsprache)
The persistence of latent HIV-1 reservoirs remains a critical barrier to functional curing AIDS, as current latency-reversing agents (LRAs) exhibit limited clinical efficacy. While RNA modifications like N⁶-methyladenosine (m⁶A) regulate viral replication, their role in maintaining HIV-1 latency is poorly defined. Here, we identify the RNA-binding protein RBM39 as a scaffold organizing an m⁶A-dependent silencing complex that enforces viral latency. Through proteomic and functional analyses, we demonstrate that RBM39 recruits the m⁶A reader YTHDC1 and the RNA helicase DDX5, forming a tripartite complex that accelerates Tat RNA decay and enforces viral quiescence. Genetic or pharmacological degradation of RBM39 (using the clinically explored molecular glue indisulam ) potently reactivates latent HIV-1 in J-Lat cell models, primary CD4⁺ T cells from people living with HIV-1 (PLWH), and synergizes with established LRAs (Bryostatin-1, JQ-1, SAHA) to broadly activate proviral reservoirs. Our work reveals a previously unrecognized host pathway in which RBM39-organized RNA decay complexes silence HIV-1 through epitranscriptomic regulation of Tat. In addition to establishing RBM39 as a promising therapeutic target for addressing the limitations of current “shock and kill” strategies, our findings establish a novel mechanistic framework for m⁶A-dependent regulation of viral gene expression. This framework may serve as a valuable reference for investigating similar regulatory mechanisms in other latent viral infections or oncogenic processes where RNA methylation plays a pivotal role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen University, Shenzhen, Guangdong, China.
- Guangdong Institute of Intelligence Science and Technology, Zhuhai, Guangdong, China.
- Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Institute of Human Virology, Department of Pathogen Biology and Biosecurity, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotech…
- Medical Research Center, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of Gastrointestinal Surgery, Shenzhen Third People's Hospital, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China.
ORCID-Profile: Ting Pan
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Deng, X., Xie, S., Zhou, M., Yuan, Q., Wu, S., Huang, P., Chen, M., Zeng, J., Guo, P., Qin, J., Chen, C., Liu, J., Liu, B., He, X., Sun, L., Zhang, H., Li, L., & Pan, T. (2025). The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003486
Vancouver
Deng X, Xie S, Zhou M, Yuan Q, Wu S, Huang P, et al. The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003486
BibTeX
@article{Deng2025,
author = {Deng, Xiaohui and Xie, Siyi and Zhou, Mo and Yuan, Quyu and Wu, Shuangxin and Huang, Peiming and Chen, Minghua and Zeng, Jianteng and Guo, Pengle and Qin, Jie and Chen, Cancan and Liu, Jiaye and Liu, Bingfeng and He, Xin and Sun, Liqin and Zhang, Hui and Li, Linghua and Pan, Ting},
title = {The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation},
journal = {PLOS Biology},
year = {2025},
doi = {10.1371/journal.pbio.3003486}
}
EUVIMED